CRYSTAL WILKERSON: Open Payments
NPI 1285219303 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 68 payments from 31 companies in 2025. Trend: 2023 $17 · 2024 $163 · 2025 $1,712
Food & beverage: $1,513Education: $199
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $190 |
| Daiichi Sankyo Inc. | 5 | $123 |
| Celgene Corporation | 4 | $102 |
| SEAGEN INC. | 1 | $100 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| Gilead Sciences, Inc. | 3 | $80 |
| Geron Corporation | 3 | $75 |
| PFIZER INC. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Lilly USA, LLC | 3 | $69 |
Products named: Enhertu, REBLOZYL, KEYTRUDA, Trodelvy, RYTELO, MI CANCER SEEK, INJECTAFER, VERZENIO.
Industry payments across TN — which companies pay providers there.
